HuGE Literature Finder
Records
1
-
26
| Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non-small cell lung cancer. Thoracic cancer 2022 Oct . Choi Sun Ha, Do Sook Kyung, Lee Shin Yup, Choi Jin Eun, Kang Hyo-Gyoung, Hong Mi Jeong, Lee Jang Hyuck, Lee Won Kee, Jeong Ji Yun, Shin Kyung Min, Do Young Woo, Lee Eung Bae, Park Ji Eun, Lee Yong Hoon, Seo Hyewon, Yoo Seung Soo, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Park Jae Yo |
| Lung cancer in never smokers from the Princess Margaret Cancer Centre. Oncotarget 2018 Apr 9 (32): 22559-22570. Korpanty Grzegorz J, Kamel-Reid Suzanne, Pintilie Melania, Hwang David M, Zer Alona, Liu Geoffrey, Leighl Natasha B, Feld Ronald, Siu Lillian L, Bedard Philippe L, Tsao Ming-Sound, Shepherd Frances |
| KRAS mutation is predictive of outcome in patients with pulmonary sarcomatoid carcinoma. Histopathology 2018 Feb . Mehrad Mitra, Roy Somak, LaFramboise William A, Petrosko Patti, Miller Caitlyn, Incharoen Pimpin, Dacic San |
| Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2018 11 125 282-290. Lin Mong-Wei, Su Kang-Yi, Su Te-Jen, Chang Chia-Ching, Lin Jing-Wei, Lee Yi-Hsuan, Yu Sung-Liang, Chen Jin-Shing, Hsieh Min-S |
| Comprehensive investigation of clinicopathologic features, oncogenic driver mutations and immunohistochemical markers in peripheral lung squamous cell carcinoma. Journal of thoracic disease 2017 Nov 9 (11): 4434-4440. Zhang Yang, Zheng Difan, Li Yuan, Pan Yunjian, Sun Yihua, Chen Haiqu |
| Adenosquamous gallbladder carcinoma: Multigene hotspot mutational profiling reveals a monoclonal origin of the two components. Pathology, research and practice 2017 May . Galuppini Francesca, Salmaso Roberta, Valentini Elisa, Lanza Cristiano, Maretto Isacco, Nitti Donato, Rugge Massimo, Fassan Matt |
| Prevalence of NRAS, PTEN and AKT1 gene mutations in the central nervous system metastases of non-small cell lung cancer. Brain tumor pathology 2017 Jan . Nico? Marcin, Krawczyk Pawe?, Jarosz Bo?ena, Sawicki Marek, Trojanowski Tomasz, Milanowski Janu |
| Comprehensive study of mutational and clinicopathologic characteristics of adenocarcinoma with lepidic pattern in surgical resected lung adenocarcinoma. Journal of cancer research and clinical oncology 2016 Oct . Xu Ye, Zhu Chen, Qian Wenliang, Zheng M |
| KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma. The American journal of surgical pathology 2016 Oct . Kadota Kyuichi, Sima Camelia S, Arcila Maria E, Hedvat Cyrus, Kris Mark G, Jones David R, Adusumilli Prasad S, Travis William |
| Analysis of mutational and clinicopathologic characteristics of lung adenocarcinoma with clear cell component. Oncotarget 2016 Mar . Gu Chang, Pan Xufeng, Wang Rui, Li Yuan, Shen Xuxia, Shi Jianxin, Chen Haiqu |
| Genetic alterations in lung adenocarcinoma with a micropapillary component. Molecular and clinical oncology 2016 Feb 4 (2): 195-200. Furukawa Masashi, Toyooka Shinichi, Ichimura Kouichi, Yamamoto Hiromasa, Soh Junichi, Hashida Shinsuke, Ouchida Mamoru, Shien Kazuhiko, Asano Hiroaki, Tsukuda Kazunori, Miyoshi Shinichi |
| Sensitive methods for screening of the MEK1 gene mutations in patients with central nervous system metastases of non-small cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2016 Feb . Nico? M, Krawczyk P, Jarosz B, Sawicki M, Michnar M, Trojanowski T, Milanowski |
| A Functional Polymorphism (rs2494752) in the AKT1 Promoter Region and Gastric Adenocarcinoma Risk in an Eastern Chinese Population. Scientific reports 2016 Jan 6 20008. Wang Meng-Yun, He Jing, Zhu Mei-Ling, Teng Xiao-Yan, Li Qiao-Xin, Sun Meng-Hong, Wang Xiao-Feng, Yang Ya-Jun, Wang Jiu-Cun, Jin Li, Wang Ya-Nong, Wei Qing- |
| Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility. Oncotarget 2015 Aug 6 (25): 20863-74. Alvi Muhammad A, McArt Darragh G, Kelly Paul, Fuchs Marc-Aurel, Alderdice Matthew, McCabe Clare M, Bingham Victoria, McGready Claire, Tripathi Shailesh, Emmert-Streib Frank, Loughrey Maurice B, McQuaid Stephen, Maxwell Perry, Hamilton Peter W, Turkington Richard, James Jacqueline A, Wilson Richard H, Salto-Tellez Manu |
| Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations. Clinical chemistry 2014 Jul 60 (7): 1004-11. Liu Xiaoying, Mody Kabir, de Abreu Francine B, Pipas J Marc, Peterson Jason D, Gallagher Torrey L, Suriawinata Arief A, Ripple Gregory H, Hourdequin Kathryn C, Smith Kerrington D, Barth Richard J, Colacchio Thomas A, Tsapakos Michael J, Zaki Bassem I, Gardner Timothy B, Gordon Stuart R, Amos Christopher I, Wells Wendy A, Tsongalis Gregory |
| Analysis of major known driver mutations and prognosis in resected adenosquamous lung carcinomas. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2014 Jun 9 (6): 760-8. Wang Rui, Pan Yunjian, Li Chenguang, Zhang Huibiao, Garfield David, Li Yuan, Ye Ting, Hu Haichuan, Luo Xiaoyang, Li Hang, Zhang Yang, Zhang Jie, Zhou Xiaoyan, Shen Lei, Pao William, Sun Yihua, Chen Haiqu |
| Assessment of mutational profile of Japanese lung adenocarcinoma patients by multitarget assays: a prospective, single-institute study. Cancer 2014 May 120 (10): 1471-81. Serizawa Masakuni, Koh Yasuhiro, Kenmotsu Hirotsugu, Isaka Mitsuhiro, Murakami Haruyasu, Akamatsu Hiroaki, Mori Keita, Abe Masato, Hayashi Isamu, Taira Tetsuhiko, Maniwa Tomohiro, Takahashi Toshiaki, Endo Masahiro, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyu |
| Molecular profiling of small cell lung cancer in a Japanese cohort. Lung cancer (Amsterdam, Netherlands) 2014 May 84 (2): 139-44. Wakuda Kazushige, Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Isaka Mitsuhiro, Takahashi Shoji, Ono Akira, Taira Tetsuhiko, Naito Tateaki, Murakami Haruyasu, Mori Keita, Endo Masahiro, Nakajima Takashi, Ohde Yasuhisa, Takahashi Toshiaki, Yamamoto Nobuyu |
| AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients. PloS one 2014 9 (9): e108057. Avan Abolfazl, Avan Amir, Le Large Tessa Y S, Mambrini Andrea, Funel Niccola, Maftouh Mina, Ghayour-Mobarhan Majid, Cantore Maurizio, Boggi Ugo, Peters Godefridus J, Pacetti Paola, Giovannetti Eli |
| PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup. PloS one 2014 9 (2): e88291. Wang Lei, Hu Haichuan, Pan Yunjian, Wang Rui, Li Yuan, Shen Lei, Yu Yongfu, Li Hang, Cai Deng, Sun Yihua, Chen Haiqu |
| Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays. BMC cancer 2014 14 786. Kenmotsu Hirotsugu, Serizawa Masakuni, Koh Yasuhiro, Isaka Mitsuhiro, Takahashi Toshiaki, Taira Tetsuhiko, Ono Akira, Maniwa Tomohiro, Takahashi Shoji, Mori Keita, Endo Masahiro, Abe Masato, Hayashi Isamu, Nakajima Takashi, Ohde Yasuhisa, Yamamoto Nobuyu |
| Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012 Nov . Rekhtman N, Tafe LJ, Chaft JE, Wang L, Arcila ME, Colanta A, Moreira AL, Zakowski MF, Travis WD, Sima CS, Kris MG, Ladanyi M |
| Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Feb 18 (4): 1167-76. Rekhtman Natasha, Paik Paul K, Arcila Maria E, Tafe Laura J, Oxnard Geoffrey R, Moreira Andre L, Travis William D, Zakowski Maureen F, Kris Mark G, Ladanyi Ma |
| Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling. Molecular cancer therapeutics 2012 Feb 11 (2): 485-91. Chaft Jamie E, Arcila Maria E, Paik Paul K, Lau Christopher, Riely Gregory J, Pietanza M Catherine, Zakowski Maureen F, Rusch Valerie, Sima Camelia S, Ladanyi Marc, Kris Mark |
| Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Feb 27 (6): 857-71. Hildebrandt Michelle A T, Yang Hushan, Hung Mien-Chie, Izzo Julie G, Huang Maosheng, Lin Jie, Ajani Jaffer A, Wu Xife |
| AKT1 and AKT2 mutations in lung cancer in a Japanese population. Molecular medicine reports 0 1 (5): 663-6. Sasaki Hidefumi, Okuda Katsuhiro, Kawano Osamu, Yukiue Haruhiro, Yano Motoki, Fujii Yoshita |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: